Scientists Take Step Forward Toward Developing HIV Vaccine
May 22, 2009 |
Despite more than two decades of intense research efforts, scientists are yet to come up with an effective vaccine against the human immunodeficiency virus (HIV). The ideal vaccine against HIV, scientists say, should efficiently prevent virus transmission and at the same time be provided at very low cost to allow widespread use in developing countries. Plants have been used as biofactories to produce HIV antigens as potential components of an AIDS vaccine. Inexpensive and effective plant-sourced vaccines may prove to be beneficial, particularly in developing countries.
Recently a team of researchers from Örebro University in Sweden reported that they have been successful in producing the HIV antigen p24 in transgenic plants. P24, a component of the HIV particle capsid, is the major target of T-cell-mediated immune responses in HIV-positive individuals.
Mice that have been fed with the p24-accumulating plants have reacted and formed antibodies against the protein. "It is highly probable that the human immune system will respond in the same manner, but this is not to say that this would be sufficient to provide complete protection," said Ingrid Lindh, lead researcher on the project. To increase the potency of the vaccine, the researchers are going to add more HIV proteins together with other compounds that reinforce the body's reaction to HIV-specific proteins. They will also express the p24 antigen in a "vegetable that is easy to cultivate in different climates and is readily accepted in different cultures."
For the complete story, read http://www.alphagalileo.org/ViewItem.aspx?ItemId=57761&CultureCode=en
|
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- PGE Study: Positive Socio-Economic and Environmental Contributions from GM Crops
- UN-Supported Project to Benefit Burundi’s Small Farmers
- Discussion on Implications of GM Crops for Small-holder African Farmers
- UV Exposure Makes Lettuce Healthier
- Ontario Invests $3.2 Million in Genomics Research
- A Sweet Idea: Converting Watermelon Juice into Ethanol
- Candidate Sites for Crop Biofortification in Latin America
- Peru Holds its First National Biotech Conference
- Limited Release of GM Sugarcane in Australia
- Study of Plant Viruses in SI White Clover Pastures
- Malaysian Scientists Successful in Cracking Oil Palm Genome
- Malaysia to Announce Regulation Framework Under Biosafety Act
- Victoria Forges Alliance with Dow Agro
- Aberystwyth University Lands UK Grant to Sequence Ryegrass Genome
-
Research Highlights
- Biotech Rice to Prevent Hypertension
- Scientists Take Step Forward Toward Developing HIV Vaccine
- Plastic and Fuel that Grow on Trees
- Pea-Derived Vaccine Against Rabbit Hemorrhagic Disease
-
Announcements
- ISAAA Video on "Knowledge, Technology & Poverty Alleviation" Available in 14 Languages
- TWAS Regional Young Scientists’ Conference
- Global Crop Protection Summit
- BCP Congress in Glasgow
- Plant Biotechnology Conference in Africa
-
Resources
- FAO: How to Run an Agribusiness
-
Read the latest: - Biotech Updates (December 11, 2024)
- Gene Editing Supplement (December 11, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet